相关实验视频

Updated: Jul 9, 2026

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage

Published on: January 17, 2013

奇洛斯塔通过减轻微循环功能障碍来缓解次大脑下出血后的延迟脑缺血

Masato Naraoka¹, Norihito Shimamura², Hiroki Ohkuma²

¹Department of Advanced Emergency and Disaster Medical Center, Hirosaki University School of Medicine & Hospital, 53 Honcho, Hirosaki, 036-8563, Japan. nessun@hirosaki-u.ac.jp.

Translational stroke research

|November 19, 2024

概括

奇洛斯塔改善了脑微循环,并改善了患有动脉瘤下关节出血 (aSAH) 的患者的治疗结果. 这种代酶3抑制剂可以通过增强血液流动来缓解延迟脑缺血 (DCI),特别是在预后不佳的人群中.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
关键护理医学关键护理医学

背景情况:

延迟大脑缺血症 (DCI) 是动脉瘤下关节出血 (aSAH) 后的一个主要并发症,通常与早期脑损伤和微循环功能障碍有关.
基洛斯塔是一种具有抗血小板性质的二酶3 (PDE3) 抑制剂,正在研究其治疗DCI的潜力.
需要阐明西洛斯塔可能对aSAH患者有益的确切机制,特别是关于微循环的机制.

研究的目的:

调查西洛斯塔对aSAH患者大脑微循环功能的影响.
为了确定西洛斯塔是否改善脑内循环时间 (iCCT) 并影响aSAH患者的结果.
探讨西洛斯塔治疗,微循环变化以及DCI和不良结果的发生之间的关系.

主要方法:

来自两项随机对照试验的256名aSAH患者的脑内循环时间 (iCCT) 分析.
在基线和随访 (亚急性阶段或DCI发病) 测量,接受西洛斯塔,皮塔瓦斯塔丁或安慰剂的组之间的iCCT的比较.
多变量分析以确定有利和不利结果的预测因素,包括西洛斯塔治疗,DCI和临床严重程度 (亨特和赫斯等级).

主要成果:

用西洛斯塔治疗的患者表现出更短的随访iCCT和更大的iCCT差异,表明微循环功能得到改善.
这些微循环改善在患有DCI且结果不佳的患者中更为明显.
奇洛斯塔治疗成为有利结果的重要预测因素,而DCI,减少iCCT差异和高临床严重程度与不良结果有关.

结论:

奇洛斯塔治疗似乎可以改善aSAH患者的大脑微循环功能,可能通过减轻微循环功能障碍.
这种微循环的改善可能有助于缓解DCI,并改善aSAH后患者的治疗结果.
建议进行进一步的研究,以证实这些发现,并在这一背景下调查西洛斯塔的剂量反应关系.

关键词:

动脉瘤下arachnoid出血动脉瘤下arachnoid出血动脉瘤下arachnoid出血延迟的大脑缺血症延迟的大脑缺血早期脑损伤是什么意思大脑内循环时间微循环功能障碍微循环功能障碍

更多相关视频

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice

Published on: December 29, 2016

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice

Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice

Published on: January 23, 2019

相关概念视频

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...